BioSpace News Archive

Hannestad will be responsible for Alkahest’s clinical programs in Alzheimer’s and Parkinson’s Disease.

Avista Pharma Solutions announced today that it has completed the acquisition of Solid Form Solutions, Ltd. located in Edinburgh, Scotland. Solid Form Solutions is a leading provider of solid state chemistry and crystallization development services for clients in the pharmaceutical industry.

The new planned 150,000 square-foot facility, located in Maryland’s Anne Arundel County, will facilitate Paragon’s continued rapid growth.

Hearingbenefit.com is the company’s dedicated direct-to-consumer website store which completes the purchase phase for the consumer.

In the preclinical study, a murine model of cancer was used to assess the effects of BL-8040 in combination with a cancer vaccine that primes the immune system against the tumor.

he Permit is valid through June 2018, at which time the facility and its operations will be reviewed by MDAQMD. Upon a favorable review the permit can be renewed for one year.

This validated European Patent is an important addition to Aethlon Medical’s patent portfolio as it protects methods for quantifying any type of exosome captured by lectin affinity.

Be The Match BioTherapies®, an organization offering solutions for delivering cellular therapies, today announced that it has invested in Tmunity Therapeutics, a private clinical-stage biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy.

Carestream Health, Inc. was awarded 36 new patents from the U.S. Patent and Trademark Office last year for innovation in radiography; cone beam CT imaging; healthcare IT; and other areas.

The CR delays the tax for 2018 and 2019, retroactive to January 1. Upon passage, Kelly Slone, President and CEO, BioUtah, issued the following statement.